세계의 바디 컨투어링 기기 시장 : 제품 유형, 최종 사용자 및 지역별: 세계 산업 분석, 규모, 점유율, 성장, 동향 및 예측(2024-2031년)

Persistence Market Research conducts an in-depth analysis of the global Body Contouring Devices Market, offering insights into market dynamics, growth drivers, challenges, and emerging trends. This report serves as a comprehensive guide for stakeholders, providing detailed data and statistics to navigate the market landscape.

The global body contouring devices market is anticipated to witness substantial growth during the forecast period from 2024 to 2031, with a projected CAGR of 15%. The market is estimated to expand from USD 1.8 billion in 2024 to USD 4.8 billion by 2031.

Key Insights:

• Estimated Market Value (2024): USD 1.8 Billion
• Projected Market Value (2031): USD 4.8 Billion
• Global Market Growth Rate (CAGR 2024 to 2031): 15%

Body Contouring Devices Market - Report Scope:

Body contouring devices encompass a range of non-invasive and minimally invasive procedures designed to reshape and redefine the body's contours. These devices target areas such as abdomen, thighs, arms, and buttocks, offering solutions for fat reduction, skin tightening, and cellulite reduction.

The growing emphasis on aesthetic appearance, coupled with technological advancements in cosmetic procedures, drives the demand for body contouring devices. Factors such as rising obesity rates, increasing disposable income, and growing awareness about cosmetic treatments contribute to market growth.

Market Growth Drivers:

The body contouring devices market is propelled by several factors, including the rising prevalence of obesity and overweight populations worldwide. As individuals seek ways to achieve a more sculpted physique, the demand for non-surgical body contouring procedures increases. Technological advancements, such as radiofrequency, ultrasound, and cryolipolysis-based devices, offer effective and safer alternatives to traditional surgical procedures.

Moreover, the expanding aging population, coupled with the desire for youthful appearance, drives demand for skin tightening and cellulite reduction treatments. Additionally, the availability of financing options and the proliferation of medical tourism further contribute to market growth.

Market Restraints:

Despite its promising growth trajectory, the body contouring devices market faces certain challenges. Concerns regarding the safety and efficacy of non-invasive procedures may hinder market adoption, particularly among cautious consumers. Regulatory scrutiny and reimbursement limitations for cosmetic procedures also pose challenges for market expansion.

Moreover, the high cost associated with advanced body contouring devices and treatments may limit access for certain patient demographics. Additionally, the emergence of alternative treatments, such as injectables and surgical procedures, may divert market share from non-invasive body contouring devices.

Market Opportunities:

The body contouring devices market presents several opportunities for innovation and expansion. Advancements in technology, such as multi-modal approaches combining different energy sources, enhance treatment outcomes and patient satisfaction. Furthermore, expanding applications beyond traditional body contouring, such as facial rejuvenation and vaginal rejuvenation, broaden the market scope.

Geographically, emerging markets in Asia Pacific and Latin America offer significant growth potential due to increasing disposable income, changing lifestyles, and growing awareness about aesthetic procedures. Strategic partnerships, mergers, and acquisitions enable companies to expand their product portfolios and geographic presence, driving market penetration.

Key Questions Addressed in the Report:

• What is the Expected Value CAGR of the Body Contouring Devices Market from 2024 to 2031?
• What are the Key Factors Driving the Growth of the Body Contouring Devices Market?
• Which Region Holds the Largest Market Share in the Body Contouring Devices Market?
• Who are the Key Players in the Global Body Contouring Devices Market?
• What Strategies are Adopted by Leading Companies to Sustain Growth in the Body Contouring Devices Market?

Competitive Landscape and Business Strategies:

Prominent players in the body contouring devices market include Alma Lasers, Ltd., Cynosure, Inc. (a subsidiary of Hologic, Inc.), Syneron Medical Ltd. (a subsidiary of Apax Partners), and Lumenis Ltd. These companies focus on product innovation, research and development, and strategic collaborations to maintain market leadership.

Key strategies adopted by leading players include launching advanced body contouring devices with enhanced safety profiles and superior efficacy. Moreover, investment in clinical research and marketing initiatives aimed at increasing patient awareness and education is crucial for market expansion.

Key Companies Profiled:

• Alma Lasers, Ltd.
• Cynosure, Inc. (a subsidiary of Hologic, Inc.)
• Syneron Medical Ltd. (a subsidiary of Apax Partners)
• Lumenis Ltd.
• Cutera, Inc.
• Venus Concept Ltd.
• Solta Medical, Inc. (a subsidiary of Bausch Health Companies Inc.)
• InMode Ltd.
• BTL Industries Inc.
• Zimmer MedizinSysteme GmbH

Body Contouring Devices Market Segmentation:

By Type

• Non-invasive and Minimally Invasive Devices
• Invasive Devices

By Application type

• Nonsurgical skin Resurfacing
• Nonsurgical skin tightening
• Cellulite treatment
• Liposuction
• Others

By Region

• North America
• Latin America
• Europe
• APAC
• MEA

Table of Contents

1. Executive Summary

• 1.1. Global Market Outlook
• 1.2. Demand-side Trends
• 1.3. Supply-side Trends
• 1.4. Technology Roadmap Analysis
• 1.5. Analysis and Recommendations

2. Market Overview

• 2.1. Market Coverage / Taxonomy
• 2.2. Market Definition / Scope / Limitations

3. Market Background

• 3.1. Market Dynamics
  • 3.1.1. Drivers
  • 3.1.2. Restraints
  • 3.1.3. Opportunity
  • 3.1.4. Trends
• 3.2. Scenario Forecast
  • 3.2.1. Demand in Optimistic Scenario
  • 3.2.2. Demand in Likely Scenario
  • 3.2.3. Demand in Conservative Scenario
• 3.3. Opportunity Map Analysis
• 3.4. Product Life Cycle Analysis
• 3.5. Supply Chain Analysis
  • 3.5.1. Supply Side Participants and their Roles
    • 3.5.1.1. Producers
    • 3.5.1.2. Mid-Level Participants (Traders/ Agents/ Brokers)
    • 3.5.1.3. Wholesalers and Distributors
  • 3.5.2. Value Added and Value Created at Node in the Supply Chain
  • 3.5.3. List of Raw Material Suppliers
  • 3.5.4. List of Existing and Potential Buyer's
• 3.6. Investment Feasibility Matrix
• 3.7. Value Chain Analysis
  • 3.7.1. Profit Margin Analysis
  • 3.7.2. Wholesalers and Distributors
  • 3.7.3. Retailers
• 3.8. PESTLE and Porter's Analysis
• 3.9. Regulatory Landscape
  • 3.9.1. By Key Regions
  • 3.9.2. By Key Countries
• 3.10. Regional Parent Market Outlook
• 3.11. Production and Consumption Statistics
• 3.12. Import and Export Statistics

4. Global Body Contouring Devices Market Analysis 2019-2023 and Forecast, 2024-2031

• 4.1. Historical Market Size Value (US$ Mn) & Volume (Units) Analysis, 2019-2023
• 4.2. Current and Future Market Size Value (US$ Mn) & Volume (Units) Projections, 2024-2031
  • 4.2.1. Y-o-Y Growth Trend Analysis
  • 4.2.2. Absolute $ Opportunity Analysis

5. Global Body Contouring Devices Market Analysis 2019-2023 and Forecast 2024-2031, By Type

• 5.1. Introduction / Key Findings
• 5.2. Historical Market Size Value (US$ Mn) & Volume (Units) Analysis By Type, 2019-2023
• 5.3. Current and Future Market Size Value (US$ Mn) & Volume (Units) Analysis and Forecast By Type, 2024-2031
  • 5.3.1. Non-invasive and Minimally Invasive Devices
  • 5.3.2. Invasive Devices
• 5.4. Y-o-Y Growth Trend Analysis By Type, 2019-2023
• 5.5. Absolute $ Opportunity Analysis By Type, 2024-2031

6. Global Body Contouring Devices Market Analysis 2019-2023 and Forecast 2024-2031, By Application Type

• 6.1. Introduction / Key Findings
• 6.2. Historical Market Size Value (US$ Mn) & Volume (Units) Analysis By Application Type, 2019-2023
• 6.3. Current and Future Market Size Value (US$ Mn) & Volume (Units) Analysis and Forecast By Application Type, 2024-2031
  • 6.3.1. Nonsurgical Skin Resurfacing
  • 6.3.2. Nonsurgical Skin Tightening
  • 6.3.3. Cellulite Treatment
  • 6.3.4. Liposuction
  • 6.3.5. Others
• 6.4. Y-o-Y Growth Trend Analysis By Application Type, 2019-2023
• 6.5. Absolute $ Opportunity Analysis By Application Type, 2024-2031

7. Global Body Contouring Devices Market Analysis 2019-2023 and Forecast 2024-2031, By Region

• 7.1. Introduction
• 7.2. Historical Market Size Value (US$ Mn) & Volume (Units) Analysis By Region, 2019-2023
• 7.3. Current Market Size Value (US$ Mn) & Volume (Units) Analysis and Forecast By Region, 2024-2031
  • 7.3.1. North America
  • 7.3.2. Latin America
  • 7.3.3. Europe
  • 7.3.4. Asia Pacific
  • 7.3.5. MEA
• 7.4. Market Attractiveness Analysis By Region

8. North America Body Contouring Devices Market Analysis 2019-2023 and Forecast 2024-2031, By Country

• 8.1. Historical Market Size Value (US$ Mn) & Volume (Units) Trend Analysis By Market Taxonomy, 2019-2023
• 8.2. Market Size Value (US$ Mn) & Volume (Units) Forecast By Market Taxonomy, 2024-2031
  • 8.2.1. By Country
    • 8.2.1.1. U.S.
    • 8.2.1.2. Canada
  • 8.2.2. By Type
  • 8.2.3. By Application Type
• 8.3. Market Attractiveness Analysis
  • 8.3.1. By Country
  • 8.3.2. By Type
  • 8.3.3. By Application Type
• 8.4. Key Takeaways

9. Latin America Body Contouring Devices Market Analysis 2019-2023 and Forecast 2024-2031, By Country

• 9.1. Historical Market Size Value (US$ Mn) & Volume (Units) Trend Analysis By Market Taxonomy, 2019-2023
• 9.2. Market Size Value (US$ Mn) & Volume (Units) Forecast By Market Taxonomy, 2024-2031
  • 9.2.1. By Country
    • 9.2.1.1. Brazil
    • 9.2.1.2. Mexico
    • 9.2.1.3. Rest of Latin America
  • 9.2.2. By Type
  • 9.2.3. By Application Type
• 9.3. Market Attractiveness Analysis
  • 9.3.1. By Country
  • 9.3.2. By Type
  • 9.3.3. By Application Type
• 9.4. Key Takeaways

10. Europe Body Contouring Devices Market Analysis 2019-2023 and Forecast 2024-2031, By Country

• 10.1. Historical Market Size Value (US$ Mn) & Volume (Units) Trend Analysis By Market Taxonomy, 2019-2023
• 10.2. Market Size Value (US$ Mn) & Volume (Units) Forecast By Market Taxonomy, 2024-2031
  • 10.2.1. By Country
    • 10.2.1.1. Germany
    • 10.2.1.2. U.K.
    • 10.2.1.3. France
    • 10.2.1.4. Spain
    • 10.2.1.5. Italy
    • 10.2.1.6. Rest of Europe
  • 10.2.2. By Type
  • 10.2.3. By Application Type
• 10.3. Market Attractiveness Analysis
  • 10.3.1. By Country
  • 10.3.2. By Type
  • 10.3.3. By Application Type
• 10.4. Key Takeaways

11. Asia Pacific Body Contouring Devices Market Analysis 2019-2023 and Forecast 2024-2031, By Country

• 11.1. Historical Market Size Value (US$ Mn) & Volume (Units) Trend Analysis By Market Taxonomy, 2019-2023
• 11.2. Market Size Value (US$ Mn) & Volume (Units) Forecast By Market Taxonomy, 2024-2031
  • 11.2.1. By Country
    • 11.2.1.1. China
    • 11.2.1.2. Japan
    • 11.2.1.3. South Korea
    • 11.2.1.4. Singapore
    • 11.2.1.5. Thailand
    • 11.2.1.6. Indonesia
    • 11.2.1.7. Australia
    • 11.2.1.8. New Zealand
    • 11.2.1.9. Rest of Asia Pacific
  • 11.2.2. By Type
  • 11.2.3. By Application Type
• 11.3. Market Attractiveness Analysis
  • 11.3.1. By Country
  • 11.3.2. By Type
  • 11.3.3. By Application Type
• 11.4. Key Takeaways

12. MEA Body Contouring Devices Market Analysis 2019-2023 and Forecast 2024-2031, By Country

• 12.1. Historical Market Size Value (US$ Mn) & Volume (Units) Trend Analysis By Market Taxonomy, 2019-2023
• 12.2. Market Size Value (US$ Mn) & Volume (Units) Forecast By Market Taxonomy, 2024-2031
  • 12.2.1. By Country
    • 12.2.1.1. GCC Countries
    • 12.2.1.2. South Africa
    • 12.2.1.3. Israel
    • 12.2.1.4. Rest of MEA
  • 12.2.2. By Type
  • 12.2.3. By Application Type
• 12.3. Market Attractiveness Analysis
  • 12.3.1. By Country
  • 12.3.2. By Type
  • 12.3.3. By Application Type
• 12.4. Key Takeaways

13. Key Countries Body Contouring Devices Market Analysis

• 13.1. U.S.
  • 13.1.1. Pricing Analysis
  • 13.1.2. Market Share Analysis, 2024
    • 13.1.2.1. By Type
    • 13.1.2.2. By Application Type
• 13.2. Canada
  • 13.2.1. Pricing Analysis
  • 13.2.2. Market Share Analysis, 2024
    • 13.2.2.1. By Type
    • 13.2.2.2. By Application Type
• 13.3. Brazil
  • 13.3.1. Pricing Analysis
  • 13.3.2. Market Share Analysis, 2024
    • 13.3.2.1. By Type
    • 13.3.2.2. By Application Type
• 13.4. Mexico
  • 13.4.1. Pricing Analysis
  • 13.4.2. Market Share Analysis, 2024
    • 13.4.2.1. By Type
    • 13.4.2.2. By Application Type
• 13.5. Germany
  • 13.5.1. Pricing Analysis
  • 13.5.2. Market Share Analysis, 2024
    • 13.5.2.1. By Type
    • 13.5.2.2. By Application Type
• 13.6. U.K.
  • 13.6.1. Pricing Analysis
  • 13.6.2. Market Share Analysis, 2024
    • 13.6.2.1. By Type
    • 13.6.2.2. By Application Type
• 13.7. France
  • 13.7.1. Pricing Analysis
  • 13.7.2. Market Share Analysis, 2024
    • 13.7.2.1. By Type
    • 13.7.2.2. By Application Type
• 13.8. Spain
  • 13.8.1. Pricing Analysis
  • 13.8.2. Market Share Analysis, 2024
    • 13.8.2.1. By Type
    • 13.8.2.2. By Application Type
• 13.9. Italy
  • 13.9.1. Pricing Analysis
  • 13.9.2. Market Share Analysis, 2024
    • 13.9.2.1. By Type
    • 13.9.2.2. By Application Type
• 13.10. China
  • 13.10.1. Pricing Analysis
  • 13.10.2. Market Share Analysis, 2024
    • 13.10.2.1. By Type
    • 13.10.2.2. By Application Type
• 13.11. Japan
  • 13.11.1. Pricing Analysis
  • 13.11.2. Market Share Analysis, 2024
    • 13.11.2.1. By Type
    • 13.11.2.2. By Application Type
• 13.12. South Korea
  • 13.12.1. Pricing Analysis
  • 13.12.2. Market Share Analysis, 2024
    • 13.12.2.1. By Type
    • 13.12.2.2. By Application Type
• 13.13. Singapore
  • 13.13.1. Pricing Analysis
  • 13.13.2. Market Share Analysis, 2024
    • 13.13.2.1. By Type
    • 13.13.2.2. By Application Type
• 13.14. Thailand
  • 13.14.1. Pricing Analysis
  • 13.14.2. Market Share Analysis, 2024
    • 13.14.2.1. By Type
    • 13.14.2.2. By Application Type
• 13.15. Indonesia
  • 13.15.1. Pricing Analysis
  • 13.15.2. Market Share Analysis, 2024
    • 13.15.2.1. By Type
    • 13.15.2.2. By Application Type
• 13.16. Australia
  • 13.16.1. Pricing Analysis
  • 13.16.2. Market Share Analysis, 2024
    • 13.16.2.1. By Type
    • 13.16.2.2. By Application Type
• 13.17. New Zealand
  • 13.17.1. Pricing Analysis
  • 13.17.2. Market Share Analysis, 2024
    • 13.17.2.1. By Type
    • 13.17.2.2. By Application Type
• 13.18. GCC Countries
  • 13.18.1. Pricing Analysis
  • 13.18.2. Market Share Analysis, 2024
    • 13.18.2.1. By Type
    • 13.18.2.2. By Application Type
• 13.19. South Africa
  • 13.19.1. Pricing Analysis
  • 13.19.2. Market Share Analysis, 2024
    • 13.19.2.1. By Type
    • 13.19.2.2. By Application Type
• 13.20. Israel
  • 13.20.1. Pricing Analysis
  • 13.20.2. Market Share Analysis, 2024
    • 13.20.2.1. By Type
    • 13.20.2.2. By Application Type

14. Market Structure Analysis

• 14.1. Competition Dashboard
• 14.2. Competition Benchmarking
• 14.3. Market Share Analysis of Top Players
  • 14.3.1. By Regional
  • 14.3.2. By Type
  • 14.3.3. By Application Type

15. Competition Analysis

• 15.1. Competition Deep Dive
  • 15.1.1. Cynosure, Inc.
    • 15.1.1.1. Overview
    • 15.1.1.2. Product Portfolio
    • 15.1.1.3. Profitability by Market Segments
    • 15.1.1.4. Sales Footprint
    • 15.1.1.5. Strategy Overview
      • 15.1.1.5.1. Marketing Strategy
      • 15.1.1.5.2. Product Strategy
      • 15.1.1.5.3. Channel Strategy
  • 15.1.2. Alma Lasers
    • 15.1.2.1. Overview
    • 15.1.2.2. Product Portfolio
    • 15.1.2.3. Profitability by Market Segments
    • 15.1.2.4. Sales Footprint
    • 15.1.2.5. Strategy Overview
      • 15.1.2.5.1. Marketing Strategy
      • 15.1.2.5.2. Product Strategy
      • 15.1.2.5.3. Channel Strategy
  • 15.1.3. Allergan Plc
    • 15.1.3.1. Overview
    • 15.1.3.2. Product Portfolio
    • 15.1.3.3. Profitability by Market Segments
    • 15.1.3.4. Sales Footprint
    • 15.1.3.5. Strategy Overview
      • 15.1.3.5.1. Marketing Strategy
      • 15.1.3.5.2. Product Strategy
      • 15.1.3.5.3. Channel Strategy
  • 15.1.4. Merz Pharma Gmbh
    • 15.1.4.1. Overview
    • 15.1.4.2. Product Portfolio
    • 15.1.4.3. Profitability by Market Segments
    • 15.1.4.4. Sales Footprint
    • 15.1.4.5. Strategy Overview
      • 15.1.4.5.1. Marketing Strategy
      • 15.1.4.5.2. Product Strategy
      • 15.1.4.5.3. Channel Strategy
  • 15.1.5. Candela Medical Ltd.
    • 15.1.5.1. Overview
    • 15.1.5.2. Product Portfolio
    • 15.1.5.3. Profitability by Market Segments
    • 15.1.5.4. Sales Footprint
    • 15.1.5.5. Strategy Overview
      • 15.1.5.5.1. Marketing Strategy
      • 15.1.5.5.2. Product Strategy
      • 15.1.5.5.3. Channel Strategy
  • 15.1.6. Solta Medical Bausch Health Companies, Inc.
    • 15.1.6.1. Overview
    • 15.1.6.2. Product Portfolio
    • 15.1.6.3. Profitability by Market Segments
    • 15.1.6.4. Sales Footprint
    • 15.1.6.5. Strategy Overview
      • 15.1.6.5.1. Marketing Strategy
      • 15.1.6.5.2. Product Strategy
      • 15.1.6.5.3. Channel Strategy
  • 15.1.7. Lutronic Corporation
    • 15.1.7.1. Overview
    • 15.1.7.2. Product Portfolio
    • 15.1.7.3. Profitability by Market Segments
    • 15.1.7.4. Sales Footprint
    • 15.1.7.5. Strategy Overview
      • 15.1.7.5.1. Marketing Strategy
      • 15.1.7.5.2. Product Strategy
      • 15.1.7.5.3. Channel Strategy
  • 15.1.8. InMode Ltd
    • 15.1.8.1. Overview
    • 15.1.8.2. Product Portfolio
    • 15.1.8.3. Profitability by Market Segments
    • 15.1.8.4. Sales Footprint
    • 15.1.8.5. Strategy Overview
      • 15.1.8.5.1. Marketing Strategy
      • 15.1.8.5.2. Product Strategy
      • 15.1.8.5.3. Channel Strategy
  • 15.1.9. Fotona
    • 15.1.9.1. Overview
    • 15.1.9.2. Product Portfolio
    • 15.1.9.3. Profitability by Market Segments
    • 15.1.9.4. Sales Footprint
    • 15.1.9.5. Strategy Overview
      • 15.1.9.5.1. Marketing Strategy
      • 15.1.9.5.2. Product Strategy
      • 15.1.9.5.3. Channel Strategy
  • 15.1.10. Sofwave Medical LTD
    • 15.1.10.1. Overview
    • 15.1.10.2. Product Portfolio
    • 15.1.10.3. Profitability by Market Segments
    • 15.1.10.4. Sales Footprint
    • 15.1.10.5. Strategy Overview
      • 15.1.10.5.1. Marketing Strategy
      • 15.1.10.5.2. Product Strategy
      • 15.1.10.5.3. Channel Strategy
  • 15.1.11. Sciton Inc
    • 15.1.11.1. Overview
    • 15.1.11.2. Product Portfolio
    • 15.1.11.3. Profitability by Market Segments
    • 15.1.11.4. Sales Footprint
    • 15.1.11.5. Strategy Overview
      • 15.1.11.5.1. Marketing Strategy
      • 15.1.11.5.2. Product Strategy
      • 15.1.11.5.3. Channel Strategy
  • 15.1.12. Lumenis
    • 15.1.12.1. Overview
    • 15.1.12.2. Product Portfolio
    • 15.1.12.3. Profitability by Market Segments
    • 15.1.12.4. Sales Footprint
    • 15.1.12.5. Strategy Overview
      • 15.1.12.5.1. Marketing Strategy
      • 15.1.12.5.2. Product Strategy
      • 15.1.12.5.3. Channel Strategy

16. Assumptions & Acronyms Used

17. Research Methodology